FdaApplication
NDA 212888
Identifiers
- fda_app_no: NDA212888
Properties
| Property | Value |
|---|---|
| applicant_name | VIIV HEALTHCARE CO |
| application_type | NDA |
| approval_date | 2021-01-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | 600MG/3ML (200MG/ML);900MG/3ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | 400MG/2ML (200MG/ML);600MG/2ML (300MG/ML) | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
2 products